Have a personal or library account? Click to login
NGAL – Urinary Biomarker With Pathologic Significance in Nephrology Practice Cover

NGAL – Urinary Biomarker With Pathologic Significance in Nephrology Practice

Open Access
|Jul 2019

References

  1. 1. Liyanage T et all Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015 May; 385 (9981):1975-82. Epub 2015 Mar 13
  2. 2. Nathan R Hill et all Global Prevalence of Chronic Kidney Disease A systematic Review and Meta-Analysis. PloS One 2016; 11(7): e015876510.1371/journal.pone.0158765
  3. 3. Trairak Pisitkun et all, Discovery of Urinary Biomarkers Molecular & Cellular Proteomics October 1, 2006, First published on July 12, 2006, 5 (10) 1760-1771;10.1074/mcp.R600004-MCP200
  4. 4. Kjeldsen L et all Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993 May 15;268(14):10425-32.10.1016/S0021-9258(18)82217-7
  5. 5. Monisha J et all. Neutrophil Gelatinase-Associated Lipocalin (NGAL): A Promising Biomarker for Cancer Diagnosis and A Potential Target for Cancer Therapeutics. J Cell Sci Molecul Biol. 2014;1(2): 106.
  6. 6. KDIGO Clinical Practice Guideline for Acute Kidney Injury
  7. 7. Susantitaphong P et all World Incidence of AKI: A Meta-Analysis. Clin J Am Soc Nephrol. 2013 Sep 6; 8(9):1482-149310.2215/CJN.00710113
  8. 8. American Society of Nephrology Renal Research Report JASN July 20105,16 (7) 1886-1903; DOI: https://doi.org/10.1681/ASN.200503028510.1681/ASN.2005030285
  9. 9. Zhou F et all Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis European Journal of Cardio-Thoracic Surgery, Volume 49, Issue 3, 1 March 2016, Pages 746755, http://doi.org/10.1093/ejcts/ezv19910.1093/ejcts/ezv199
  10. 10. Sachin S. Soni et all Early Diagnosis of Acute Kidney Injury: The Promise of Novel Biomarkers Blood Purif 2009;28:165174 DOI: 10.1159/000227785 Published online: July 8, 200910.1159/000227785
  11. 11. Taub Pam et all Role of Biomarkers in the Diagnosis and Prognosis of Acute Kidney Injury in Patients With Cardiorenal Syndrome Expert Rev Cardiovasc Ther. 2012;10(5):657-667.10.1586/erc.12.26
  12. 12. Jaya M et all Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:25342543.10.1097/01.ASN.0000088027.54400.C6
  13. 13. Jaya M et all: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231 1238.10.1016/S0140-6736(05)74811-X
  14. 14. Dent CL et all: Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11:R127.10.1186/cc6192224622318070344
  15. 15. Hirsch R, et all: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007;22:20892095.10.1007/s00467-007-0601-4
  16. 16. Zappitelli M et all: Urine neutrophil gelatinase associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007; 11:R8410.1186/cc6089220651917678545
  17. 17. de Geus HR et all, The cardiac surgeryassociated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: A potential tool to monitor acute tubular damage J Thorac Cardiovasc Surg. 2016 Jun;151(6):1476-81. doi: 10.1016/j.jtcvs.2016.01.037. Epub 2016 Feb 12.10.1016/j.jtcvs.2016.01.037.Epub2016Feb12
  18. 18. Dent C et all Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study Crit Care. 2007; 11(6): R127.Published online 2007 Dec 10. doi: 10.1186/cc6192
  19. 19. Klein S, Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis Intensive Care Med. 2018; 44(3): 323336.Published online 2018 Mar 14. doi: 10.1007/s00134-018-5126-810.1007/s00134-018-5126-8586117629541790
  20. 20. Batuman V Chronic Glomerulonephritis Feb 01, 2017 www.medscape.com
  21. 21. Mircescu G Glomerulopatiile, Ed enciclopedica, Bucuresti, 2016
  22. 22. Ding H Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007 May;123(2):227-34. Epub 2007 Mar 13.10.1016/j.clim.2007.01.01017360238
  23. 23. Wang F Neutrophil degranulation in antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis. J Nephrol. 2009 Jul-Aug;22(4):491-6.
  24. 24. Torres-Salido MT et all Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis Nephrology Dialysis Transplantation, Volume 29,Issue 9, 1 September 2014, Pages 17401749, http://doi.org/10.1093/ndt/gfu06210.1093/ndt/gfu06224711435
  25. 25. Rhee H et all, High serum and urine neutrophil gelatinase associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy Korean J Intern Med. 2015 May; 30(3): 354361.Published online 2015 Ap doi: 10.3904/kjim.2015.30.3.35410.3904/kjim.2015.30.3.354443829025995666
  26. 26. Tramonti G Review and Discussion of Tubular Biomarkers in the Diagnosis and Management of Diabetic Nephropathy Endocrine. Author manuscript; available in PMC 2014 Jun 1.Published in final edited form as: Endocrine. 2013 Jun; 43(3): 494503. Published online 2012 Oct 20. doi: 10.1007/s12020-012-9820-y10.1007/s12020-012-9820-y367082023086402
  27. 27. Fu WJ et all. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract. 2012;95:105109.,10.1016/j.diabres.2011.09.03122015481
  28. 28. Stine E. Nielsen et all, Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.10.1038/ki.2010.55421270761
  29. 29. Edward R. Smith and all Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD) Nephrology Dialysis Transplantation, Volume 28, Issue 6, June 2013, Pages 15691579, https://doi.org/10.1093/ndt/gfs586 Published:16 January 201310.1093/ndt/gfs58623328709
  30. 30. Corbacýoglu, SK et al. “Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD).” Turkish journal of emergency medicine vol. 17,3 85-88. 3 Jun. 2017, doi:10.1016/.tjem.2017.03.00210.1016/.tjem.2017.03.002
DOI: https://doi.org/10.2478/inmed-2019-0056 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 7 - 18
Published on: Jul 18, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Mădălina-Gabriela Stăncescu, Mircea Penescu, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.